Compare VNRX & ORIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNRX | ORIO |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 20.1M |
| IPO Year | 2012 | 2014 |
| Metric | VNRX | ORIO |
|---|---|---|
| Price | $0.44 | $0.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.67 | N/A |
| AVG Volume (30 Days) | ★ 626.8K | 29.9K |
| Earning Date | 05-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $355.66 | $74.52 |
| Revenue Next Year | $849.08 | $5.07 |
| P/E Ratio | ★ N/A | $4.93 |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $0.61 |
| 52 Week High | $3.26 | $1.40 |
| Indicator | VNRX | ORIO |
|---|---|---|
| Relative Strength Index (RSI) | 19.99 | 60.38 |
| Support Level | $0.18 | $0.82 |
| Resistance Level | $0.91 | $0.96 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 1.72 | 71.49 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.